Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Huons Global (084110 KS)
Watchlist
40
Analysis
Health Care
•
South Korea
Huons Co., Ltd. manufactures pharmaceutical products. The Company produces medical drugs in the fields of nervous system, sensory organs, anti-histamines, circulatory system, respiratory system, digestive system, metabolic agents and hormones.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Coocon Corp
•
24 Nov 2021 20:11
KOSDAQ150 Index Rebalance: Pullback Done; Buy Adds & Sell Deletes
There are 15 changes for the KOSDAQ150 index in December. The impact on the deletions is larger than that on the inclusions. A long adds/short...
Brian Freitas
Follow
602 Views
Share
bullish
•
M2N Co.,Ltd
•
02 Nov 2021 13:43
KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover
At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...
Brian Freitas
Follow
888 Views
Share
bearish
•
Hugel Inc
•
15 Aug 2021 05:44
The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?
The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.
Douglas Kim
Follow
690 Views
Share
bullish
•
Wonik QnC Corp
•
05 Aug 2021 07:44
KOSDAQ150 Index Rebalance Preview: Inclusions Outperforming as Short Sell Ban Helps
Halfway through the review period, we see 15 potential changes to the index. The potential inclusions are outperforming the exclusions as short...
Brian Freitas
Follow
513 Views
Share
bullish
•
Wonik QnC Corp
•
07 Jun 2021 13:33
KOSDAQ150 Index Rebalance Preview: Lots of Changes Early in the Review Period
A month into the review period for the KOSDAQ150 December rebalance, we can already see 12 potential changes. The potential inclusions should...
Brian Freitas
Follow
449 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x